Juan Enrique Schwarze1,2, Paula Borda1, Pamela Vásquez3, Carolina Ortega2, Sonia Villa2, Javier A Crosby4, Ricardo Pommer2. 1. Clinical Departament of Obstetrics and Gynecology, Universidad de Santiago, Chile. 2. Unit of Reproductive Medicine, Clínica Monteblanco, Santiago, Chile. 3. School of Dentistry, Universidad de los Andes, Santiago, Chile. 4. Unit of Reproductive Medicine, Clínica Las Condes, Santiago, Chile.
Abstract
OBJECTIVE: Preeclampsia (PE) occurs in 4.6% of pregnancies worldwide. The social phenomenon of increasing maternal age has raised the demand for donor oocytes. Egg donation has allowed women with poor ovarian reserve, premature ovarian failure, genetic disorders or surgical menopause to get pregnant. Recipients provide a unique model of immune response because of the differences in the genetic makeup of mothers and fetuses. In PE, immune tolerance may be impaired as a result of having non-autologous eggs implanted. Egg donation is a highly successful assisted reproductive technology, despite the significant number of issues arising from the implantation of non-autologous eggs. This study aimed to determine whether there is an association between egg donation and preeclampsia. METHODS: A systematic review of the literature available in PubMed and Google Scholar was carried out from January of 1995 to August of 2016 using the terms 'oocyte donation, preeclampsia', 'oocyte donation, in vitro fertilization, preeclampsia', 'oocyte donation, preeclampsia, outcomes pregnancies', 'oocyte donation, obstetric outcome.' Only six retrospective cohort studies met the selection criteria. RESULTS: The meta-analysis revealed a statistically significant association between egg donation and onset of preeclampsia (OR 4.50; 95% CI: 3.28-6.19; p<0.0001). CONCLUSION: Oocyte donation is associated with increased risk of preeclampsia in singleton pregnancies. Therefore, it is crucial to properly record and assess this finding when egg donation is the chosen assisted reproductive technology to attain pregnancy.
OBJECTIVE:Preeclampsia (PE) occurs in 4.6% of pregnancies worldwide. The social phenomenon of increasing maternal age has raised the demand for donor oocytes. Egg donation has allowed women with poor ovarian reserve, premature ovarian failure, genetic disorders or surgical menopause to get pregnant. Recipients provide a unique model of immune response because of the differences in the genetic makeup of mothers and fetuses. In PE, immune tolerance may be impaired as a result of having non-autologous eggs implanted. Egg donation is a highly successful assisted reproductive technology, despite the significant number of issues arising from the implantation of non-autologous eggs. This study aimed to determine whether there is an association between egg donation and preeclampsia. METHODS: A systematic review of the literature available in PubMed and Google Scholar was carried out from January of 1995 to August of 2016 using the terms 'oocyte donation, preeclampsia', 'oocyte donation, in vitro fertilization, preeclampsia', 'oocyte donation, preeclampsia, outcomes pregnancies', 'oocyte donation, obstetric outcome.' Only six retrospective cohort studies met the selection criteria. RESULTS: The meta-analysis revealed a statistically significant association between egg donation and onset of preeclampsia (OR 4.50; 95% CI: 3.28-6.19; p<0.0001). CONCLUSION: Oocyte donation is associated with increased risk of preeclampsia in singleton pregnancies. Therefore, it is crucial to properly record and assess this finding when egg donation is the chosen assisted reproductive technology to attain pregnancy.
Entities:
Keywords:
in vitro fertilization; oocyte donation; preeclampsia
Authors: Wendy van Dorp; Annemarie M Rietveld; Joop S E Laven; Marry M van den Heuvel-Eibrink; Chantal W P M Hukkelhoven; Izaäk Schipper Journal: Eur J Obstet Gynecol Reprod Biol Date: 2014-09-16 Impact factor: 2.435
Authors: Sara S Malchau; Anne Loft; Elisabeth C Larsen; Anna-Karina Aaris Henningsen; Steen Rasmussen; Anders Nyboe Andersen; Anja Pinborg Journal: Fertil Steril Date: 2013-03-07 Impact factor: 7.329
Authors: Dominic Stoop; Miriam Baumgarten; Patrick Haentjens; Nikolaos P Polyzos; Michel De Vos; Greta Verheyen; Michel Camus; Paul Devroey Journal: Reprod Biol Endocrinol Date: 2012-06-06 Impact factor: 5.211
Authors: Manon Bos; Mirthe H Schoots; Bernadette O Fernandez; Monika Mikus-Lelinska; Laurie C Lau; Michael Eikmans; Harry van Goor; Sanne J Gordijn; Andreas Pasch; Martin Feelisch; Marie-Louise P van der Hoorn Journal: Int J Mol Sci Date: 2019-03-06 Impact factor: 5.923